Media coverage
13Media coverage
Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet Plus Company Updates (PCU) Country United States Date 6/7/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet Plus Company Updates (PCU) Country United States Date 6/6/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet TMC Net Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet TMC Net Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet BioSpace Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet 4 Traders Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet Stockwatch Country Canada Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet Customer Zone 360.com Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet India Pharma News Country India Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet GlobeNewswire Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet Daily Times Leader Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet PrimeNewswire (Top News) Country United States Date 6/5/17 Persons Andrew Brenner Title New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti-Tumor Activity of VB-111 in Recurrent GBM Media name/outlet EIN News Country United States Date 6/5/17 Persons Andrew Brenner